Literature DB >> 11455856

Stem cell transplantation for autoimmune diseases.

J Moore1, P Brooks.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11455856     DOI： 10.1007/s002810100059

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  78 in total

1.  Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

Authors:  M Diviné; D Boutolleau; M H Delfau-Larue; F Beaujean; H Jouault; F Reyes; M Kuentz; A Bensussan; J P Farcet; L Boumsell
Journal:  Br J Haematol       Date:  1999-05       Impact factor: 6.998

2.  New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.

Authors:  G Socié; R E Curtis; H J Deeg; K A Sobocinski; A H Filipovich; L B Travis; K M Sullivan; P A Rowlings; D W Kingma; P M Banks; W D Travis; R P Witherspoon; J Sanders; E S Jaffe; M M Horowitz
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

3.  Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.

Authors:  R A Brodsky; M Petri; B D Smith; E J Seifter; J L Spivak; M Styler; C V Dang; I Brodsky; R J Jones
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

4.  Total lymphoid irradiation--not for rheumatoid arthritis.

Authors:  P Rackoff; T Feldman
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

5.  Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.

Authors:  H J Sutherland; G M Fyles; G Adams; Y Hao; J H Lipton; M D Minden; J M Meharchand; H Atkins; I Tejpar; H A Messner
Journal:  Bone Marrow Transplant       Date:  1997-06       Impact factor: 5.483

6.  Remission of nonerosive polyarthritis associated with Sjögren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma.

Authors:  K Jondeau; C Job-Deslandre; D Bouscary; N Khanlou; C J Menkes; F Dreyfus
Journal:  J Rheumatol       Date:  1997-12       Impact factor: 4.666

7.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

Authors:  M Attal; J L Harousseau; A M Stoppa; J J Sotto; J G Fuzibet; J F Rossi; P Casassus; H Maisonneuve; T Facon; N Ifrah; C Payen; R Bataille
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

8.  Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.

Authors:  S Mackinnon; L Barnett; G Heller; R J O'Reilly
Journal:  Blood       Date:  1994-06-01       Impact factor: 22.113

9.  Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

Authors:  R A Brodsky; L L Sensenbrenner; R J Jones
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

10.  Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.

Authors:  T Ishida; M Inaba; H Hisha; K Sugiura; Y Adachi; N Nagata; R Ogawa; R A Good; S Ikehara
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.